476 related articles for article (PubMed ID: 24623107)
61. Activity of coumarin against Candida albicans biofilms.
Xu K; Wang JL; Chu MP; Jia C
J Mycol Med; 2019 Apr; 29(1):28-34. PubMed ID: 30606640
[TBL] [Abstract][Full Text] [Related]
62. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
Vila TV; Ishida K; de Souza W; Prousis K; Calogeropoulou T; Rozental S
J Antimicrob Chemother; 2013 Jan; 68(1):113-25. PubMed ID: 22995097
[TBL] [Abstract][Full Text] [Related]
63. Identification, characterization and evaluation of novel antifungal cyclic peptides from Neobacillus drentensis.
Routhu SR; Ragi NC; Yedla P; Shaik AB; Venkataraman G; Cheemalamarri C; Chityala GK; Amanchy R; Sripadi P; Kamal A
Bioorg Chem; 2021 Oct; 115():105180. PubMed ID: 34332234
[TBL] [Abstract][Full Text] [Related]
64. Inhibitory activity of surfactin, produced by different Bacillus subtilis subsp. subtilis strains, against Listeria monocytogenes sensitive and bacteriocin-resistant strains.
Sabaté DC; Audisio MC
Microbiol Res; 2013 Mar; 168(3):125-9. PubMed ID: 23265790
[TBL] [Abstract][Full Text] [Related]
65. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
Cateau E; Rodier MH; Imbert C
J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
[TBL] [Abstract][Full Text] [Related]
66. Non-antifungal drugs inhibit growth, morphogenesis and biofilm formation in Candida albicans.
Kathwate GH; Shinde RB; Mohan Karuppayil S
J Antibiot (Tokyo); 2021 May; 74(5):346-353. PubMed ID: 33469194
[TBL] [Abstract][Full Text] [Related]
67. In vitro method to study antifungal perfusion in Candida biofilms.
Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
[TBL] [Abstract][Full Text] [Related]
68. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
69. Boesenbergia rotunda extract inhibits Candida albicans biofilm formation by pinostrobin and pinocembrin.
Kanchanapiboon J; Kongsa U; Pattamadilok D; Kamponchaidet S; Wachisunthon D; Poonsatha S; Tuntoaw S
J Ethnopharmacol; 2020 Oct; 261():113193. PubMed ID: 32730867
[TBL] [Abstract][Full Text] [Related]
70. Antagonistic effects of Bacillus subtilis subsp. subtilis and B. amyloliquefaciens against Macrophomina phaseolina: SEM study of fungal changes and UV-MALDI-TOF MS analysis of their bioactive compounds.
Torres MJ; Brandan CP; Petroselli G; Erra-Balsells R; Audisio MC
Microbiol Res; 2016 Jan; 182():31-9. PubMed ID: 26686611
[TBL] [Abstract][Full Text] [Related]
71. Induction of Candida albicans biofilm formation on silver-coated vascular grafts.
Tammer I; Reuner J; Hartig R; Geginat G
J Antimicrob Chemother; 2014 May; 69(5):1282-5. PubMed ID: 24448486
[TBL] [Abstract][Full Text] [Related]
72. Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans.
Padmavathi AR; Bakkiyaraj D; Thajuddin N; Pandian SK
Biofouling; 2015; 31(7):565-74. PubMed ID: 26299260
[TBL] [Abstract][Full Text] [Related]
73. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells.
Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M
Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454
[TBL] [Abstract][Full Text] [Related]
74. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil.
Sudjana AN; Carson CF; Carson KC; Riley TV; Hammer KA
Med Mycol; 2012 Nov; 50(8):863-70. PubMed ID: 22587732
[TBL] [Abstract][Full Text] [Related]
75. The Activity of Fungichromin against the Formation of Candida albicans Biofilm.
An D; Wang X; Li J; Jiang S; Ma X; Zhang H; Shi H; Sun H; Ye L; Li J
Biol Pharm Bull; 2016 Dec; 39(12):1948-1954. PubMed ID: 27615430
[TBL] [Abstract][Full Text] [Related]
76. The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans.
Cheng A; Sun L; Wu X; Lou H
Biol Pharm Bull; 2009 Aug; 32(8):1417-21. PubMed ID: 19652383
[TBL] [Abstract][Full Text] [Related]
77. In Vitro Effects of Plantago Major Extract, Aucubin, and Baicalein on Candida albicans Biofilm Formation, Metabolic Activity, and Cell Surface Hydrophobicity.
Shirley KP; Windsor LJ; Eckert GJ; Gregory RL
J Prosthodont; 2017 Aug; 26(6):508-515. PubMed ID: 26618515
[TBL] [Abstract][Full Text] [Related]
78. Biophysical Effects of a Polymeric Biosurfactant in Candida krusei and Candida albicans Cells.
Ferreira GF; Dos Santos Pinto BL; Souza EB; Viana JL; Zagmignan A; Dos Santos JR; Santos ÁR; Tavares PB; Denadai ÂM; Monteiro AS
Mycopathologia; 2016 Dec; 181(11-12):799-806. PubMed ID: 27567919
[TBL] [Abstract][Full Text] [Related]
79. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
80. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
Kathwate GH; Karuppayil SM
Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
